Titan Medical Inc. Completes Amadeus Composer(TM) Pre-Production Console and Video Tower
Dec 01, 2011
TORONTO, ONTARIO–(Marketwire – Dec. 1, 2011) – Titan Medical Inc. (“the Company”) (TSX VENTURE:TMD) announced today that it has completed prototypes of the pre-production Surgeon Console and Video Tower, and Beta Patient Cart of its Amadeus Composer™ platform. The pre-production versions of the Surgeon Console and Video Tower are in the final phases of development and Titan plans to move forward to final design for manufacture and testing.
Craig Leon, Chief Executive Officer of Titan Medical Inc., commented, “I am extremely pleased with the efforts and dedication of our engineering team and development partners in completing the Console and Video Tower of Amadeus Composer™ on schedule. This marks a significant advancement in Titan Medical’s development cycle. We are now committed to proceeding to our next major milestone of tissue and animal feasibility studies by the middle of 2012.”
Amadeus Composer™ is a next generation surgical system that has a uniquely designed external robot and flexible instruments which allow surgeons to overcome constraints of surgical procedures in small to medium spaces. Amadeus Composer™ is designed for use in robotic surgery procedures such as thoracic (lung), ENT (ear, nose and throat), general surgical procedures as well as other surgical cases that are performed in very small and tight spaces. Other elements that make up the Amadeus™ Robotic Surgical System include communications, simulation systems and haptics
"The Amadeus will be better suited for these procedures through the use of less rigid instrument shafts made from lighter-weight carbon fillers. Not only will they be easier to manoeuvre, but they will also offer a better line of sight through the laparoscopic port via advanced 3-D imaging." "The Amadeus will be better suited for these procedures through the use of less rigid instrument shafts made from lighter-weight carbon fillers. Not only will they be easier to manoeuvre, but they will also offer a better line of sight through the laparoscopic port via advanced 3-D imaging."
Reiza Rayman MD is the president of Titan Medical and holds a distinctive PhD in robotic surgery.
Reiza Rayman MD is the president of Titan Medical and holds a distinctive PhD in robotic surgery.
This rare combination of knowledge and perspective has helped spearhead what may be the first significant competitor to Intuitive Surgical’s da Vinci® surgical system.
In an exclusive Q&A, Rayman offers some insight on his company’s recently completed prototype, the impact it will have on telemedicine capabilities and how the company’s Amadeus® will distinguish itself from a well-known market leader.
How about some background on Titan Medical?
We’re a North American-based company developing Amadeus, a next generation 4-armed robotic surgical system with advancements in navigation and positioning, communication and vision that we believe will allow physicians to use robots in a significantly greater number of surgical procedures.
How will Amadeus potentially differ from the da Vinci?
In my opinion, the da Vinci is primarily focused on and well-suited for prostate procedures and hysterectomies. We want to expand those capabilities to include bowel surgeries, as well as more delicate areas like the heart – specifically procedures centering on the mitral valve.
The Amadeus will be better suited for these procedures through the use of less rigid instrument shafts made from lighter-weight carbon fillers. Not only will they be easier to manoeuvre, but they will also offer a better line of sight through the laparoscopic port via advanced 3-D imaging.
Specially designed sensors and a new type of motor feedback system will also offer a quicker and more intuitive feedback mechanism when the instruments contact surrounding areas. Additionally, these advanced controls will provide a better tactile feel when suturing.
Also, we’ve gone to great lengths in working to position the Amadeus as a great teaching and information sharing system. I can’t go into great detail, but the communicative capabilities will allow for more surgeons and trainees to view and share their surgical expertise over greater distances Also, simulation capabilities, based on software borrowed from aerospace applications, will be embedded so surgeons can become familiar with more of the equipment’s operation and students can obtain a higher quality of training on robotic surgery.
We feel that in addition to expanding the application range of robotic surgical equipment, the Amadeus will play a prominent role in expanding telemedicine’s use and implementation.
What progress has been made in developing the Amadeus?
We have developed our first working prototype. We are now moving forward to the final clinical device stage, which should be ready for clinical trials in 18 to 24 months.
Market Data 
Markets 
AI
